|
1
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013. View Article : Google Scholar
|
|
2
|
Ali R, Mirza Z, Ashraf GM, et al: New
anticancer agents: recent developments in tumor therapy. Anticancer
Res. 32:2999–3005. 2012.PubMed/NCBI
|
|
3
|
Parkinson DR, Arbuck SG, Moore T, Pluda JM
and Christian MC: Clinical development of anticancer agents from
natural products. Stem Cells. 12:30–43. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tsukagoshi S: Recent trend on the
development of new anticancer drugs. Gan To Kagaku Ryoho.
20:425–431. 1993.(In Japanese).
|
|
5
|
Wang H, Guo S, Qian D, Qian Y and Duan JA:
Comparative analysis of quinolizidine alkaloids from different
parts of Sophora alopecuroides seeds by UPLC-MS/MS. J Pharm
Biomed Anal. 67–68:16–21. 2012.PubMed/NCBI
|
|
6
|
Zhang L, Jiang J and Tan R: Effects of
matrine on telomerase activity and cell cycle in K562 cell.
Zhonghua Zhong Liu Za Zhi. 20:328–329. 1998.(In Chinese).
|
|
7
|
Zhang LP, Jiang JK, Tam JW, et al: Effects
of matrine on proliferation and differentiation in K-562 cells.
Leuk Res. 25:793–800. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang Z, Wang X, Wu W, et al: Effects of
matrine on proliferation and apoptosis in gallbladder carcinoma
cells (GBC-SD). Phytother Res. 26:932–937. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan C, Lu SQ and Yao X: Effects of
oxymatrine on the antitumor activity and toxicity of
cyclophosphamide in mice. Yao Xue Xue Bao. 22:245–249.
1987.PubMed/NCBI
|
|
10
|
Li XM, Wu YG, Chen SL, Pan DX, Wu JN and
Yu YH: Antitumor action of sophoridine. Zhongguo Yao Li Xue Bao.
8:153–158. 1987.(In Chinese).
|
|
11
|
Liang L, Wang XY, Zhang XH, et al:
Sophoridine exerts an anti-colorectal carcinoma effect through
apoptosis induction in vitro and in vivo. Life Sci. 91:1295–1303.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yuan XY, Liu W, Zhang P, Wang RY and Guo
JY: Effects and mechanisms of aloperine on 2,
4-dinitrofluorobenzene-induced allergic contact dermatitis in
BALB/c mice. Eur J Pharmacol. 629:147–152. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin Z, Huang CF, Liu XS and Jiang J: In
vitro anti-tumour activities of quinolizidine alkaloids derived
from Sophora flavescens Ait. Basic Clin Pharmacol Toxicol.
108:304–309. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhou CC, Gao HB, Sun XB, et al:
Anti-inflammatory and anti-allergic action of aloperine. Zhongguo
Yao Li Xue Bao. 10:360–365. 1989.(In Chinese).
|
|
15
|
Lin WC and Lin JY: Five bitter compounds
display different anti-inflammatory effects through modulating
cytokine secretion using mouse primary splenocytes in vitro. J
Agric Food Chem. 59:184–192. 2011. View Article : Google Scholar
|
|
16
|
Franken NA, Rodermond HM, Stap J, Haveman
J and van Bree C: Clonogenic assay of cells in vitro. Nat Protoc.
1:2315–2319. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xi S, Gooding WE and Grandis JR: In vivo
antitumor efficacy of STAT3 blockade using a transcription factor
decoy approach: implications for cancer therapy. Oncogene.
24:970–979. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhu Z, Li E, Liu Y, et al: Inhibition of
Jak-STAT3 pathway enhances bufalin-induced apoptosis in colon
cancer SW620 cells. World J Surg Oncol. 10:2282012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lu Y, Zhou J, Xu C, et al: JAK/STAT and
PI3K/AKT pathways form a mutual transactivation loop and afford
resistance to oxidative stress-induced apoptosis in cardiomyocytes.
Cell Physiol Biochem. 21:305–314. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Debatin KM and Krammer PH: Death receptors
in chemotherapy and cancer. Oncogene. 23:2950–2966. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin Z and El-Deiry WS: Overview of cell
death signaling pathways. Cancer Biol Ther. 4:139–163.
2005.PubMed/NCBI
|
|
22
|
Hu W, Shen T and Wang MH: Cell cycle
arrest and apoptosis induced by methyl 3,5-dicaffeoyl quinate in
human colon cancer cells: Involvement of the PI3K/Akt and MAP
kinase pathways. Chem Biol Interact. 194:48–57. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Itoh K, Hase H, Kojima H, Saotome K,
Nishioka K and Kobata T: Central role of mitochondria and p53 in
Fas-mediated apoptosis of rheumatoid synovial fibroblasts.
Rheumatology (Oxford). 43:277–285. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reed JC: Bcl-2 family proteins. Oncogene.
17:3225–3236. 1998. View Article : Google Scholar
|
|
25
|
Tsujimoto Y: Role of Bcl-2 family proteins
in apoptosis: apoptosomes or mitochondria? Genes Cells. 3:697–707.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Brooks G and La Thangue NB: The cell cycle
and drug discovery: the promise and the hope. Drug Discov Today.
4:455–464. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Flatt PM and Pietenpol JA: Mechanisms of
cell-cycle checkpoints: at the crossroads of carcinogenesis and
drug discovery. Drug Metab Rev. 32:283–305. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kwak YT, Radaideh SM, Ding L, et al: Cells
lacking IKKα show nuclear cyclin D1 overexpression and a neoplastic
phenotype: role of IKKα as a tumor suppressor. Mol Cancer Res.
9:341–349. 2011.
|
|
29
|
Bunz F, Dutriaux A, Lengauer C, et al:
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Darnell JE Jr, Kerr IM and Stark GR:
Jak-STAT pathways and transcriptional activation in response to
IFNs and other extracellular signaling proteins. Science.
264:1415–1421. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Turkson J: STAT proteins as novel targets
for cancer drug discovery. Expert Opin Ther Targets. 8:409–422.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Lin L, Liu A, Peng Z, et al: STAT3 is
necessary for proliferation and survival in colon cancer-initiating
cells. Cancer Res. 71:7226–7237. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Turkson J and Jove R: STAT proteins: novel
molecular targets for cancer drug discovery. Oncogene.
19:6613–6626. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Nishimoto A, Kugimiya N, Hosoyama T, Enoki
T, Li TS and Hamano K: JAB1 regulates unphosphorylated STAT3
DNA-binding activity through protein-protein interaction in human
colon cancer cells. Biochem Biophys Res Commun. 438:513–518. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Jia SS, Xi GP, Zhang M, et al: Induction
of apoptosis by D-limonene is mediated by inactivation of Akt in
LS174T human colon cancer cells. Oncol Rep. 29:349–354.
2013.PubMed/NCBI
|
|
36
|
Harashima N, Inao T, Imamura R, Okano S,
Suda T and Harada M: Roles of the PI3K/Akt pathway and autophagy in
TLR3 signaling-induced apoptosis and growth arrest of human
prostate cancer cells. Cancer Immunol Immunother. 61:667–676. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu Y, Mei C, Sun L, et al: The PI3K-Akt
pathway regulates calpain 6 expression, proliferation, and
apoptosis. Cell Signal. 23:827–836. 2011. View Article : Google Scholar : PubMed/NCBI
|
